Our findings provide new insights into a critical role for SPRY4 as a regulator of adipogenic differentiation, which may illuminate the underlying mechanisms of obesity and suggest the potential of SPRY4 as a novel treatment option. Here, SPRY4 is linked to obesity due to melanocortin 4 receptor deficiency.